Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Gelsenkirchen

6 clinical trials in Gelsenkirchen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Gelsenkirchen at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Gelsenkirchen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Gilead Sciences Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Skin-Derived Abcb5-Positive Dermal Mesenchymal Stromal Cells
  • Sponsor:Rheacell GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:WSG Women's Cancer Study Group GmbH

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Gelsenkirchen

What the registry says about research in the country

01 Breast Cancer Research

Groundbreaking studies focusing on HR+/HER2- early breast cancer treatment optimization through personalized therapeutic approaches.

  • Endocrine Therapy Enhancement
  • Personalized Treatment Strategies
  • Disease-Free Survival Improvement

Advanced clinical investigations combining targeted therapies with standard treatments to enhance patient outcomes.

02 Triple-Negative Breast Cancer

Innovative research exploring neoadjuvant treatment combinations for early-stage triple-negative breast cancer patients.

  • Novel Drug Combinations
  • Post-Surgery Treatment Optimization
  • Recurrence Risk Reduction

Focused trials evaluating cutting-edge therapeutic approaches for improved survival rates.

03 Wound Healing Studies

Pioneering research into chronic venous ulcer treatment using advanced stem cell therapies.

  • Topical Stem Cell Applications
  • Non-Healing Wound Management
  • Therapeutic Resistance Solutions

Comprehensive evaluation of innovative biological treatments for persistent wound healing challenges.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.